Loading stock data…
WALD
$0.96+0.07 (+7.99%)
Market ClosedLast close May 1
Waldencast plc operates in the beauty and wellness industry in the United States, Canada, Europe, the Middle East, India, Australia, and New Zealand.
Historical Price
Price (Candle)
50-Day SMA
200-Day SMA
Whystock Brain
The Narrative
Waldencast plc in the Consumer Defensive sector is trading at $0.96. The stock is currently near its 52-week low of $0.72, remaining 44.8% below its 200-day moving average. Technical signals show neutral RSI of 43 and bullish MACD crossover, explaining why WALD maintains its current current market pressure. The Whystock Score of 15/100 signals elevated caution as indicators diverge.
Ecosystem Influences
Neutral momentum (RSI 43) — price action in range
Long-term trend bearish (Price vs 200-day SMA)
Macro-economic sensitivity to interest rate and inflation shifts
Loading Financials...
Peer Comparison
Whystock Valuation Model
Whystock fair value is estimated using a trailing P/E model adjusted for return on equity: Fair P/E = 18 + (ROE × 20). Fair Value = (Current Price ÷ Trailing P/E) × Fair P/E. A base P/E of 18 represents a typical market multiple, scaled upward for companies that earn high returns on equity. The result is a theoretical "normalised" price — not a price target or investment advice. Large deviations are common for high-growth or loss-making companies.
Current Price$0.96
Potential Upside
5%
Whystock Fair Value$1.01
Price
UndervaluedFair ValueOvervalued
Simplified model based on P/E and ROE. Not a substitute for full valuation analysis. Data may be delayed. See our Terms.
Fundamentals
Waldencast plc operates in the beauty and wellness industry in the United States, Canada, Europe, the Middle East, India, Australia, and New Zealand. The company operates through two segments, Obagi Medical and Milk Makeup. It offers skin care produc...
Market Cap
Total dollar market value of a company's outstanding shares of stock (Price * Shares).
$102.61M
P/E Ratio
Priced for growth. Investors expect sustained double-digit expansion.
-
Beta
Defensive asset. Lower volatility than the S&P 500.
-0.07
Div Yield
Low to zero yield. Return is entirely dependent on price appreciation.
0.00%
ROE
Average efficiency. Growth may require heavy reinvestment.
0.60%
Volume
Today's trading volume
1.66M
Recent News
Top Premarket Gainers
Waldencast (WALD) shares were up 31% in Wednesday premarket activity, a day after the company said t
Promising Penny Stocks To Consider In April 2026
The market has climbed 3.0% in the last 7 days and an impressive 26% over the past year, with earnings projected to grow by 16% annually in the coming years. For those looking to invest in smaller or newer companies, penny stocks — despite their somewhat outdated name — can still offer surprising value. These stocks often represent a mix of affordability and growth potential when backed by solid financials, and we will explore several that stand out for their financial strength.
Obagi Medical, It’s a Secret Med Spa collaborate for ALOHA program
Obagi Medical announced It’s a Secret Med Spa as a key partner in the Aesthetics Leadership with Obagi’s Hyaluronic Acid Program. It’s a Secret Med Spa will help generate real-world data to translate the clinical safety and efficacy demonstrated in FDA pivotal trials into everyday practice across multiple locations and structured evaluation programs.Claim 50% Off TipRanks PremiumUnlock hedge fund-level data and powerful investing tools for smarter, sharper decisions Stay ahead of the market with
How The Waldencast (WALD) Narrative Is Shifting As Outlook Resets Meet Brand Optimism
Waldencast’s fair value target is held at $3.08 per share, with no change between the prior and updated estimate. That steady target sits against a mixed analyst backdrop, where some highlight the Buy rating and long term brand potential, while others focus on weaker Q2 results, a reduced FY25 outlook and questions around execution. As you read on, you will see how to track this evolving story and what to watch as sentiment and assumptions shift over time. Analyst Price Targets don't always...
How The Story Behind Waldencast (WALD) Is Shifting In Analysts’ Eyes
Why the Waldencast Price Target Has Shifted Waldencast’s consensus analyst price target has edged from about US$3.20 to about US$3.08, a small change that still reflects a split view between long term brand potential and questions about near term execution. The slightly higher discount rate of about 9.62% compared with about 8.73% and modestly stronger revenue growth assumptions of about 6.31% compared with about 6.17% capture this tension, with optimism around the brands tempered by cautious...